Abstract: The invention relates to a method of therapy against tumors and their metastases, which preferentially settle in bone tissue, comprising administering to a patient in need thereof an active ingredient which comprises at least one binding molecule that binds to human bone sialoprotein or a fragment thereof.

Abstract: The invention relates to a medicament against tumors and their metastases, which preferentially settle in bone tissue, comprising active ingredient at least one binding molecule that binds to bone sialoprotein or a fragment thereof in serum or plasma.

Abstract: The invention relates to a medicament against tumors and their metastases, which preferentially settle in bone tissue, comprising as active ingredient at least one binding molecule which binds to bone sialoprotein or a fragment thereof in serum or plasma.

Abstract: To deplete viruses in organic material, the material to be purified is conveyed through an ultrafilter or an ultrafiltration unit the depletion rate of which is previously determined. The filter or filtration unit is charged with viruses of the family Leviviridae and the viral count is determined before and after filtration and used to derive the depletion rate. The virus depletion can be monitored during the process by following the depletion of a marker.

Abstract: The present invention provides a process for the regulation of the activa sludge step of a clarification plant by control of the decomposition efficiency of the activated sludge, wherein an activated sludge sample is incubated under precisely defined conditions, which are optimised with regard to the pH value, the temperature and the salt concentration, with the substrate or substrates of interest above the saturation range and, in the initial phase, the decrease of the substrate or the increase of a decomposition product is determined kinetically as a measure of the decomposition efficiency for this substrate and the measured value determined is used as regulating value for the control of the clarification plant.

Abstract: The present invention provides a process for the control of a biological rification stage of the aerobic activated sludge type, wherein at least one of the micro-organisms most frequently present in the activated sludge is continuously monitored with regard to the amount thereof in that, in a representative sample from the activated sludge and/or from the inlet of the activated sludge tank, this micro-organism is bound to fluorescence-labelled antibodies directed against the chosen micro-organism or this micro-organism is allowed to react with a fluorogenic substrate by means of a special metabolic ability, the amount of the thus fluorescence-labelled micro-organism is determined by flow cytometry and, at the same time, the total amount of the micro-organism present is determined by scattered light measurement and/or coloration of the DNA and, depending upon the measurement values thus obtained, the amount of at least one particular micro-organism and/or the growth conditions for this micro-organism is regula